Elevated serum matrix metalloproteinase-3 and -7 in H. Pylori-related gastric cancer can be biomarkers correlating with a poor survival

Digestive Diseases and Sciences

Volumn 55, Issue 6, 2010, Pages 1649-1657

  Yeh, Yi Chun ^a   Sheu, Bor Shyang ^a   Cheng, Hsiu Chi ^a   Wang, Yen Lin ^b   Yang, Hsiao Bai ^a   Wu, Jiunn Jong ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

Author keywords

Gastric cancer; H. pylori; MMP 3; MMP 7; MMP 9

Indexed keywords

BIOLOGICAL MARKER; GELATINASE B; MATRILYSIN; STROMELYSIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DUODENUM ULCER; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LOG RANK TEST; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; STOMACH CANCER; STOMACH ULCER;

AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77954424331     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0926-x     Document Type: Article

References (42)

1. HW Steer 1984 Surface morphology of the gastroduodenal mucosa in duodenal ulceration Gut 25 1203 1210 10.1136/gut.25.11.1203 1:STN:280: DyaL2M%2Flt1KnsA%3D%3D 6500361 (Pubitemid 15201376)
2. MB Warren JR 1983 Unidentified curved bacilli on gastric epithelium in active chronic gastritis Lancet 1 1273 1275
3. A Labigne H de Reuse 1996 Determinants of Helicobacter pylori pathogenicity Infect Agents Dis 5 191 202 1:CAS:528:DyaK28Xmt1SjsL4%3D 8884364 (Pubitemid 26317982)
4. BE Dunn H Cohen MJ Blaser 1997 Helicobacter pylori Clin Microbiol Rev 10 720 741 1:CAS:528:DyaK2sXmvFyhu7c%3D 9336670 (Pubitemid 27477732)
5. A Nomura GN Stemmermann PH Chyou, et al. 1994 Helicobacter pylori infection and the risk for duodenal and gastric ulceration Ann Intern Med 120 977 981 1:STN:280:DyaK2c3ktFCqtQ%3D%3D 7741826 (Pubitemid 24169275)
6. Web of Department of Health. Executive Yuan, Taiwan, 2009 Edition. Available at: http://www.doh.gov.tw/CHT2006/DisplayStatisticFile.aspx?d= 71700&s=1. Accessed 10.07.2009.
7. LE Wroblewski PJ Noble A Pagliocca, et al. 2003 Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells: role in epithelial cell migration J Cell Sci 116 3017 3026 10.1242/jcs.00518 1:CAS:528:DC%2BD3sXlvFyqtbY%3D 12808021 (Pubitemid 36926990)
8. N Mori H Sato T Hayashibara, et al. 2003 Helicobacter pylori induces matrix metalloproteinase-9 through activation of nuclear factor kappaB Gastroenterology 124 983 992 10.1053/gast.2003.50152 1:CAS:528: DC%2BD3sXjsFOju7s%3D 12671895 (Pubitemid 36389801)
9. HC Crawford US Krishna DA Israel, et al. 2003 Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa Gastroenterology 125 1125 1136 10.1016/S0016-5085(03)01206-X 1:CAS:528:DC%2BD3sXosFCltL8%3D 14517796 (Pubitemid 37193459)
10. JR Bebb DP Letley RJ Thomas, et al. 2003 Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner Gut 52 1408 1413 10.1136/gut.52.10.1408 1:CAS:528:DC%2BD3sXotl2lu7g%3D 12970131 (Pubitemid 37176718)
11. SL Parsons SA Watson PD Brown, et al. 1997 Matrix metalloproteinases Br J Surg 84 160 166 10.1002/bjs.1800840206 1:STN:280:DyaK2s3gsV2iug%3D%3D 9052425 (Pubitemid 27073454)
12. KH Lee SJ Shin KO Kim, et al. 2006 Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma Oncol Rep 16 823 830 1:CAS:528:DC%2BD28XhtFSisr3F 16969501
13. K Ohashi T Nemoto K Nakamura, et al. 2000 Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas Cancer 88 2201 2209 10.1002/(SICI)1097- 0142(20000515)88:10<2201::AID-CNCR2>3.0.CO;2-N 1:CAS:528: DC%2BD3cXjslSqtbw%3D 10820340 (Pubitemid 30247118)
14. M Mori GF Barnard K Mimori, et al. 1995 Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas Cancer 75 1516 1519 10.1002/1097-0142(19950315)75:6+<1516::AID-CNCR2820751522>3.0.CO;2-7 1:STN:280:DyaK2M7ps1Wktw%3D%3D 7889484
15. S Hoikkala P Paakko Y Soini, et al. 2006 Tissue MMP-2 and MMP-9 are better prognostic factors than serum MMP-2/TIMP-2-complex or TIMP-1 in stage I-III lung carcinoma Cancer Lett 236 125 132 10.1016/j.canlet.2005.05.012 1:CAS:528:DC%2BD28XjvVGgsr0%3D 15982804
16. S Zucker RM Lysik MH Zarrabi, et al. 1993 M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer Cancer Res 53 140 146 1:STN:280:DyaK3s7gsFCjsw%3D%3D 8416738 (Pubitemid 23019389)
17. H Ruokolainen P Paakko T Turpeenniemi-Hujanen 2005 Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker Int J Cancer 116 422 427 10.1002/ijc.21092 1:CAS:528:DC%2BD2MXmtl2kur0%3D 15818624 (Pubitemid 40993339)
18. CY Wu MS Wu EP Chiang, et al. 2007 Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution Clin Cancer Res 13 2054 2060 10.1158/1078-0432.CCR-06-2299 1:CAS:528:DC%2BD2sXjs12rtrk%3D 17404086 (Pubitemid 46649872)
19. G Christofori H Semb 1999 The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene Trends Biochem Sci 24 73 76 10.1016/S0968-0004(98)01343-7 1:CAS:528:DyaK1MXltFCgsr8%3D 10098402 (Pubitemid 29346577)
20. TD Tlsty 1998 Cell-adhesion-dependent influences on genomic instability and arcinogenesis Curr Opin Cell Biol 10 647 653 10.1016/S0955-0674(98)80041-0 1:CAS:528:DyaK1cXntVSgu7s%3D 9818176 (Pubitemid 28477024)
21. F Tas D Duranyildiz H Oguz, et al. 2005 Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in patients with malignant melanoma Med Oncol 22 39 44 10.1385/MO:22:1:039 1:CAS:528:DC%2BD2MXltFSjurc%3D 15750195 (Pubitemid 40647228)
22. K Gohji N Fujimoto T Komiyama, et al. 1996 Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinoma Cancer 78 2379 2387 10.1002/(SICI)1097-0142(19961201) 78:11<2379::AID-CNCR17>3.0.CO;2-Y 1:STN:280:DyaK2s%2FpsF2rtA%3D%3D 8941010 (Pubitemid 26392839)
23. H Nomura N Fujimoto M Seiki, et al. 1996 Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas Int J Cancer 69 9 16 10.1002/(SICI)1097- 0215(19960220)69:1<9::AID-IJC3>3.0.CO;2-8 1:CAS:528:DyaK28Xit1yntr8%3D 8600068 (Pubitemid 26083264)
24. GI Murray ME Duncan E Arbuckle, et al. 1998 Matrix metalloproteinases and their inhibitors in gastric cancer Gut 43 791 797 1:CAS:528:DyaK1cXotVagtrc%3D 9824606 (Pubitemid 28539658)
25. S McDonnell M Navre RJ Coffey, et al. 1991 Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas Mol Carcinog 4 527 533 10.1002/mc.2940040617 1:CAS:528: DyaK38XhvFWrsbY%3D 1793490
26. M Gooz M Shaker P Gooz, et al. 2003 Interleukin 1beta induces gastric epithelial cell matrix metalloproteinase secretion and activation during Helicobacter pylori infection Gut 52 1250 1256 10.1136/gut.52.9.1250 1:CAS:528:DC%2BD3sXnsFCgt7o%3D 12912854 (Pubitemid 37026455)
27. M Gooz P Gooz SmolkaAJ Epithelial 2001 Epithelial and bacterial metalloproteinases and their inhibitors in H. pylori infection of human gastric cells Am J Physiol Gastrointest Liver Physiol 281 G823 G832 1:CAS:528: DC%2BD3MXmvFCnt7c%3D 11518695 (Pubitemid 32879196)
28. P Kundu AK Mukhopadhyay R Patra, et al. 2006 Cag pathogenicity island-independent up-regulation of matrix metalloproteinases-9 and -2 secretion and expression in mice by Helicobacter pylori infection J Biol Chem 281 34651 34662 10.1074/jbc.M604574200 1:CAS:528:DC%2BD28XhtFKgur3O 16966323 (Pubitemid 46036671)
29. R Caruso D Fina I Peluso, et al. 2007 IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis J Immunol 178 5957 5965 1:CAS:528:DC%2BD2sXktlWhsbY%3D 17442980 (Pubitemid 46674393)
30. MF Dixon RM Genta JH Yardley 1996 Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994 Am J Surg Pathol 20 1161 1181 10.1097/00000478-199610000-00001 1:STN:280:DyaK28visVGlsg%3D%3D 8827022 (Pubitemid 26336840)
31. BS Sheu SM Sheu HB Yang, et al. 2003 Host gastric Lewis expression determines the bacterial density of Helicobacter pylori in babA2 genopositive infection Gut 52 927 932 10.1136/gut.52.7.927 1:CAS:528:DC%2BD3sXlslCru74%3D 12801945 (Pubitemid 36765280)
32. BS Sheu S Odenbreit KH Hung, et al. 2006 Interaction between host gastric Sialyl-Lewis X and H. pylori SabA enhances H. pylori density in patients lacking gastric Lewis B antigen Am J Gastroenterol 101 36 44 10.1111/j.1572-0241.2006.00358.x 1:CAS:528:DC%2BD28XhsFSrtrs%3D 16405531 (Pubitemid 43381706)
33. FL Greene 2002 The American joint committee on cancer: Updating the strategies in cancer staging Bull Am Coll Surg 87 13 15 17387902
34. P Lauren 1965 The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification Acta Pathol Microbiol Scand 64 31 49 1:STN:280: DyaF2M7isFenug%3D%3D 14320675
35. YW Chang HC Oh JY Jang, et al. 2008 IL-1beta and IL-8, matrix metalloproteinase 3, and pepsinogen secretion before and after H. pylori eradication in gastroduodenal phenotypes Scand J Gastroenterol 43 1184 1193 10.1080/00365520802130209 1:CAS:528:DC%2BD1cXhtFCiu77O 18609140
36. PJ Bergin E Anders W Sicheng, et al. 2004 Increased production of matrix metalloproteinases in Helicobacter pylori-associated human gastritis Helicobacter 9 201 210 10.1111/j.1083-4389.2004.00232.x 1:CAS:528: DC%2BD2cXltlKhsbs%3D 15165255 (Pubitemid 38724755)
37. K Endo Y Maehara H Baba, et al. 1997 Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer Anticancer Res 17 2253 2258 1:CAS:528:DyaK2sXkvFylsbY%3D 9216697 (Pubitemid 27320978)
38. A Torii Y Kodera K Uesaka, et al. 1997 Plasma concentration of matrix metalloproteinase 9 in gastric cancer Br J Surg 84 133 136 10.1002/bjs. 1800840147 1:STN:280:DyaK2s7ps1aqtQ%3D%3D 9043478 (Pubitemid 27033129)
39. M Honda M Mori H Ueo, et al. 1996 Matrix metalloproteinase-7 expression in gastric carcinoma Gut 39 444 448 10.1136/gut.39.3.444 1:STN:280: DyaK2s7gs12jtg%3D%3D 8949652 (Pubitemid 26338536)
40. FJ Kubben CF Sier W van Duijn, et al. 2006 Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer Br J Cancer 94 1035 1040 10.1038/sj.bjc.6603041 1:CAS:528:DC%2BD28XjtFGqt7o%3D 16538217
41. XP Liu S Kawauchi A Oga, et al. 2002 Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma +-Jpn J Cancer Res 93 291 295 1:CAS:528:DC%2BD38XktFSlur8%3D 11927011 (Pubitemid 34464365)
42. P Kundu AK Mukhopadhyay R Patra, et al. 2006 Cag pathogenicity island-independent up-regulation of matrix metalloproteinases-9 and -2 secretion and expression in mice by Helicobacter pylori infection J Biol Chem 281 34651 34662 10.1074/jbc.M604574200 1:CAS:528:DC%2BD28XhtFKgur3O 16966323 (Pubitemid 46036671)